COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Gimv neemt als co-leadinvesteerder deel aan een Series C financieringsronde van 30 miljoen EUR bij Onera Health.
Gimv neemt deel aan Series C financieringsronde van 30 miljoen EUR bij Onera Health, een pionier in slaapdiagnostiek en monitoring op afstand. Financiering stelt Onera Health in staat om productie en verkoop te versnellen en de ambitie te worden in hPSG binnen slaapgeneeskunde -
-
COMMUNIQUÉ RÉGLEMENTÉ
Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health
Onera Health announces completion of a €30M Series C financing round led by EQT Life Sciences and co-led by Gimv, aiming to accelerate manufacturing and sales of its innovative sleep testing solutions and become the leader in hPSG. GIMV, Series C financing, Onera Health, sleep medicine, remote sleep diagnostic, PSG system -
COMMUNIQUÉ RÉGLEMENTÉ
Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health
Onera Health, a leader in remote sleep diagnostic and monitoring solutions, has announced the successful completion of a €30M Series C financing round, co-led by Gimv and EQT Life Sciences. This funding will enable Onera Health to accelerate manufacturing and sales to meet growing customer demand for its innovative sleep testing solutions. The company aims to become the leader in home PSG (hPSG) within the field of sleep medicine by bringing clinical-grade PSG diagnostics and monitoring directly to the patient’s bed. This press release highlights the significant impact and potential of Onera Health's innovative technology in disrupting the sleep testing market. -
-
COMMUNIQUÉ RÉGLEMENTÉ
bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D
bioMérieux, a world leader in in vitro diagnostics, announces the appointment of two new Executive Committee members, Dr. Charles K. Cooper and Céline Roger-Dalbert, to lead Medical Affairs and Research & Development, respectively. Dr. Cooper brings extensive medical and leadership background from Siemens Healthcare Diagnostics and U.S. Food & Drug Administration, while Céline Roger-Dalbert boasts over 25 years of in vitro diagnostic experience, with significant contributions to new product launches and over 20 patent applications. Their nominations signify bioMérieux's commitment to addressing global patients' needs and driving innovation, aligning with the company's strategy. For more information, visit www.biomerieux.com. -
COMMUNIQUÉ DE PRESSE
Former UFC Middleweight Champion Luke Rockhold to Host Free Self-Defence Seminar in Toronto
Former UFC and Strikeforce Middleweight Champion Luke Rockhold is partnering with Toronto-based Scholars Education to present a free youth seminar on self-defense. The event will include an introduction to self-defense, a Q&A session, and a demonstration for kids, highlighting the physical and mental benefits of martial arts for youth. The seminar, taking place on Saturday, Jan. 20, will also feature special guest appearances and prize giveaways. Space is limited, so interested participants should register by sending an email to Annalisa@ScholarsEd.com. -
COMMUNIQUÉ DE PRESSE
Velox Issues New Options
Velox Energy Materials Inc. (TSXV:VLX) has granted stock options over 6 million new common shares to certain Directors and employees. The options have an exercise price of $0.05 and an expiry date of 12 January 2029. Velox Energy Materials is a publicly traded energy materials company focusing on the advanced NQV Project in Queensland, Australia, and owns Kotai Energy and the option to acquire 100% of the intellectual property rights associated with the Solid-State Hydrogen Storage Project from Curtin University in Western Australia. -
COMMUNIQUÉ DE PRESSE
Global Education Communities Corp. Reports Fiscal 2024 First Quarter Financial Results
Global Education Communities Corp. (GECC) has reported its consolidated financial statements and management's discussion and analysis for its first quarter of fiscal 2024. The company's total revenue has increased by 21% year-over-year, with significant growth in its international and domestic education businesses as well as student housing revenue. GECC's net income before income tax reached $9.13 million, and EBITDA increased to $15 million, an increase of 250% from the same period in the previous year. The company also remains optimistic about potential rate decreases in the coming quarters, which could positively impact its real estate services division. For more information, visit www.GEChq.com.
